JNJ US4781601046

Report

Real-time Estimate Cboe BZX - 05/20 04:29:21 pm EDT
177.47	USD		+2.03%

09:26a	Immix Biopharma Says Cancer Drug IMX-110 Showed Higher Survival Rate Versus Johnson & Johnson Unit's Trabectedin in Mice Study	MT
05/19	The Janssen Pharmaceutical Companies - New Data Show TREMFYA (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab	AQ
05/19	New Janssen Campaign Developed by and for the LGBTQ+ Community Inspires Action and Empathy for People Living with Depression	AQ

Calendar

Event chart JOHNSON & JOHNSON

Upcoming events on JOHNSON & JOHNSON

05/23/22		Ex-dividend day for
05/24/22 \| 10:00am		UBS Global Healthcare Conference
06/01/22 \| 10:00am		Bernstein Strategic Decisions Conference
07/19/22 \| 06:25am		Interim 2022 Earnings Release
07/19/22 \| 08:30am		Interim 2022 Earnings Call
10/18/22		Q3 2022 Earnings Release
10/18/22 \| 08:30am		Q3 2022 Earnings Call
01/24/23		FY 2022 Earnings Release (Projected)
04/18/23		Q1 2023 Earnings Release (Projected)
07/18/23		Interim 2023 Earnings Release (Projected)

Past events on JOHNSON & JOHNSON

05/11/22 \| 03:40pm		Bank of America Healthcare Conference
04/28/22 \| 10:00am		Annual General Meeting
04/19/22 \| 08:30am		Q1 2022 Earnings Call
04/19/22 \| 06:25am		Q1 2022 Earnings Release
03/08/22 \| 01:05pm		Raymond James Institutional Investors Conference
03/07/22 \| 09:10am		Cowen & Co. Health Care Conference
02/23/22 \| 11:00am		Citi Research Healthcare Conference
02/18/22		Ex-dividend day for
01/25/22 \| 08:30am		FY 2021 Earnings Call
01/25/22 \| 06:25am		FY 2021 Earnings Release

Past dividends on JOHNSON & JOHNSON

02/18/22		Quarterly 1.06 USD
11/22/21		Quarterly 1.06 USD
08/23/21		Quarterly 1.06 USD
05/24/21		Quarterly 1.06 USD
02/22/21		Quarterly 1.01 USD
11/23/20		Quarterly 1.01 USD
08/24/20		Quarterly 1.01 USD
05/22/20		Quarterly 1.01 USD
02/24/20		Quarterly 0.95 USD
11/25/19		Quarterly 0.95 USD

Annual results

Fiscal Period : January		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread	76 450 76 321 0,17%	81 581 81 416 0,20%	82 059 82 193 -0,16%	82 584 81 721 1,1%	93 775 94 304 -0,56%	96 248
Operating income (EBITDA) M $	Released Forecast Spread	24 764 25 922 -4,5%	28 104 29 996 -6,3%	27 979 28 680 -2,4%	27 145 27 951 -2,9%	36 634 33 054 11%	34 318
Operating profit (EBIT) M $	Released Forecast Spread	19 122 20 814 -8,1%	21 175 23 631 -10%	25 593 25 615 -0,09%	24 574 24 992 -1,7%	29 244 30 088 -2,8%	30 902
Pre-Tax Profit (EBT) M $	Released Forecast Spread	17 673 20 450 -14%	17 999 21 447 -16%	17 328 19 476 -11%	16 497 19 030 -13%	22 776 24 759 -8,0%	27 439
Net income M $	Released Forecast Spread	1 300 15 804 -92%	15 297 17 666 -13%	15 119 16 943 -11%	14 714 15 924 -7,6%	20 878 22 542 -7,4%	23 016
EPS $	Released Forecast Spread	0,47 5,78 -92%	5,61 6,44 -13%	5,63 6,47 -13%	5,51 6,10 -9,7%	7,81 8,42 -7,3%	8,90
Announcement Date		01/23/2018	01/22/2019	01/22/2020	01/26/2021	01/25/2022	-

Quarterly results

Fiscal Period : January

2021 Q1

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

Sales
M $

Released
Forecast
Spread

22 321
22 013
1,4%

23 312
22 510
3,6%

23 338
23 718
-1,6%

24 804
25 289
-1,9%

23 426
23 618
-0,81%

23 840

Operating income
(EBITDA)
M $

Released
Forecast
Spread

8 542
8 068
5,9%

8 097
8 084
0,17%

9 639
8 389
15%

7 939
7 408
7,2%

9 305
8 964
3,8%

8 807

Operating profit
(EBIT)
M $

Released
Forecast
Spread

6 648
7 291
-8,8%

6 258
7 358
-15%

7 825
7 625
2,6%

6 096
6 790
-10%

7 536
7 874
-4,3%

7 850

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

7 429
6 215
20%

6 662
6 154
8,3%

4 836
5 551
-13%

5 862
7 060
-17%

7 053

Net income
M $

Released
Forecast
Spread

6 197
5 951
4,1%

6 278
5 920
6,0%

3 667
6 189
-41%

4 736
5 475
-13%

EPS
$

Released
Forecast
Spread

2,32
2,10
10%

2,35
2,04
15%

1,37
2,17
-37%

1,77
1,91
-7,3%

1,93
2,30
-16%

2,28

Announcement Date

04/20/2021

07/21/2021

10/19/2021

01/25/2022

04/19/2022

Previous year

Next Year

Upcoming sector events for JOHNSON & JOHNSON

07/21/22		ROCHE HOLDING AG : Interim 2022 Earnings Release
07/29/22		ABBVIE INC. : Interim 2022 Earnings Release (Projected)
08/02/22		PFIZER INC. : Interim 2022 Earnings Release (Projected)
08/04/22 \| 06:25am		ELI LILLY AND COMPANY : Interim 2022 Earnings Release
10/18/22		ROCHE HOLDING AG : Q3 2022 Sales and Revenue Release
11/01/22		PFIZER INC. : Q3 2022 Earnings Release (Projected)
11/01/22 \| 05:25am		ELI LILLY AND COMPANY : Q3 2022 Earnings Release
11/04/22		ABBVIE INC. : Q3 2022 Earnings Release (Projected)
01/27/23		ABBVIE INC. : FY 2022 Earnings Release (Projected)
01/31/23		PFIZER INC. : FY 2022 Earnings Release (Projected)

More events

Past sector events for JOHNSON & JOHNSON

05/03/22 \| 06:45am		PFIZER INC. : Q1 2022 Earnings Release
04/29/22 \| 07:43am		ABBVIE INC. : Q1 2022 Earnings Release
04/28/22 \| 06:25am		ELI LILLY AND COMPANY : Q1 2022 Earnings Release
04/25/22 \| 01:00am		ROCHE HOLDING AG : Q1 2022 Sales and Revenue Release
02/08/22 \| 06:45am		PFIZER INC. : FY 2021 Earnings Release
02/03/22 \| 06:25am		ELI LILLY AND COMPANY : FY 2021 Earnings Release
02/03/22 \| 01:00am		ROCHE HOLDING AG : FY 2021 Earnings Release
02/02/22 \| 07:43am		ABBVIE INC. : FY 2021 Earnings Release
11/02/21 \| 05:45am		PFIZER INC. : Q3 2021 Earnings Release
10/29/21 \| 07:40am		ABBVIE INC. : Q3 2021 Earnings Release

More events

Analysis

How Johnson & Johnson became the sprawling healthcare giant it is today